BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Head and Neck Cancer

6 posts

Head and neck cancer is the second most prevalent type of cancer in the world. It accounts for 6% – 7% of all human cancers, with about 650,000 new cases diagnosed every year. It is one of the deadliest forms of cancer.

The rate of new cases has been increasing rapidly since the beginning of this century. The highest frequency is observed in Eastern Asia and in countries of the North-Atlantic region. The disease affects men more often than women.

The most common site of head and neck cancer is the oral cavity. Throat cancer (carcinoma of the larynx) is the second most common type, followed by cancers of the nasal cavity and paranasal sinuses.

Head and neck cancers arise from different cell types in the head and neck region. The cells that give rise to head and neck cancers can come from any of the following:

– Oral cavity: cancer of the lips, tongue, cheeks, gums, floor of the mouth, or roof of the mouth

– Nasal cavity and paranasal sinuses: cancer of the nose, sinuses, or nasopharynx

– Larynx: cancer of the voice box

– Salivary glands: cancer of the parotid gland, submandibular gland, or sublingual gland.

The cause of head and neck cancer is not fully understood.

RAPT Therapeutics Announces Promising Phase 2 Trial Results for Tivumecirnon

Biotech NewsRAPT Therapeutics Announces Promising Phase 2 Trial Results for Tivumecirnon

  • BioTech Health X
  • April 10, 2024
RAPT Therapeutics, a clinical-stage biopharmaceutical company, has announced promising results from its Phase 2 clinical trial of Tivumecirnon…
0 Shares
0
0
0
0
0
0
0
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

  • BioTech Health X
  • September 10, 2022
CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor…
0 Shares
0
0
0
0
0
0
0
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial

Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial

  • BioTech Health X
  • July 20, 2022
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
0 Shares
0
0
0
0
0
0
0
EF Hutton Initiates Coverage of Cel-Sci CVM with 17 Price Target Ahead of Rumored News

Biotech NewsEF Hutton Initiates Coverage of Cel-Sci (CVM) with $17 Price Target Ahead of Rumored News

  • BioTech Health X
  • April 7, 2022
Tim Moore, CFA an Analyst at EF Hutton has recently published a report citing the opportunities for growth…
0 Shares
0
0
0
0
0
0
0
Exclusive Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future

BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future

  • BioTech Health X
  • September 3, 2021
About Cel-Sci Corporation Cel-Sci Corporation is a publicly traded biotechnology business which develops, manufactures, and markets treatments focused…
0 Shares
0
0
0
0
0
0
0
Istari Oncology Begins Phase 1 : Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients

Biotech NewsIstari Oncology Begins Phase 1 / Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients

  • BioTech Health X
  • August 17, 2021
Istari Oncology, Inc., a clinical-stage biotechnology firm focused on unique immunotherapy systems for the treatment of strong lumps,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Wall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move
  • Why I-Mab (IMAB) Could Be the Next Big Breakout in Global Biotech
  • ReShape Lifesciences (RSLS) & Vyome Merger Could Create a Healthcare Powerhouse
  • Trinity Biotech (TRIB) Could Be the Next Billion-Dollar Healthcare Innovator
  • Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 14, 2025
    Wall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move
    • August 14, 2025
    Why I-Mab (IMAB) Could Be the Next Big Breakout in Global Biotech
    • August 14, 2025
    ReShape Lifesciences (RSLS) & Vyome Merger Could Create a Healthcare Powerhouse
    • August 14, 2025
    Trinity Biotech (TRIB) Could Be the Next Billion-Dollar Healthcare Innovator
    • August 13, 2025
    Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
Recent Posts
  • 180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
    • August 13, 2025
  • Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
    • August 13, 2025
  • Generation Bio (GBIO)’s $100MCash Lifeline: Is a Massive Comeback on the Horizon?
    • August 13, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (311)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top